Glutamic acid decarboxylase (GAD)65 formulated with aluminium hydroxide (GAD-alum) was effective in preserving insulin secretion inside a Phase II medical trial in children and adolescents with recent-onset type 1 diabetes. function in expanded regulatory T cells exposed no difference between GAD-alum- and placebo-treated individuals. Regulatory T cell rate of recurrence did not correlate with C-peptide… Continue reading Glutamic acid decarboxylase (GAD)65 formulated with aluminium hydroxide (GAD-alum) was effective